Powered by: Motilal Oswal
2026-08-05 05:39:00 pm | Source: PR Agency
Blockbuster listing - Manipal Health Enterprises Limited`s IPO lists at Rs 655 on the exchange, reaches a high of Rs 666.70 on BSE
News By Tags | #IPO
Blockbuster listing - Manipal Health Enterprises Limited`s IPO lists at Rs 655 on the exchange, reaches a high of Rs 666.70 on BSE

Shares of Bengaluru-based Manipal Health Enterprises Limited, which is the largest pan-India multispecialty hospital network by bed capacity as of March 31, 2026 (Source: CRISIL Report), listed at Rs 655 on the BSE with a premium of 11% to the IPO price.

The scrip reached a high of Rs 675.80 on the NSE, and Rs 676.05 on the BSE.

The scrip closed at Rs 663.15 on the NSE and Rs 666.70 on BSE.

As per NSE, the total quantity traded stood at 470.08 lakh shares, on BSE the total Quantity stood at 43.91 lakh shares. Total Turnover (BSE+NSE) on Day 1 stood at Rs 3,365.86 crore.

The Market Capitalisation of the Company at today’s closing price stood at Rs 87,696.20 crore as per BSE and Rs 87,229.24 crore as per NSE.

The issue received bids of 44,30,73,025 equity shares against the offered 9,00,88,286 equity shares, according to data available on the stock exchanges.

Qualified Institutional Buyers (QIB) and Retail Portion were subscribed 8.25 times and 0.93 times, respectively. Non-Institutional Investors (NII) portion was subscribed 1.02 times whereas the employee reserved portion subscribed 2.19 times.

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here